| First Author | Woodbury D | Year | 1998 |
| Journal | Brain Res | Volume | 803 |
| Issue | 1-2 | Pages | 95-104 |
| PubMed ID | 9729303 | Mgi Jnum | J:49425 |
| Mgi Id | MGI:1277470 | Doi | 10.1016/s0006-8993(98)00627-1 |
| Citation | Woodbury D, et al. (1998) Novel structure of the human GDNF gene. Brain Res 803(1-2):95-104 |
| abstractText | Glial cell line-derived neurotrophic factor (GDNF) is the most potent known survival factor for substantia nigra neurons, which degenerate in Parkinson's disease, for spinal motoneurons, which die in Lou Gehrig's disease (ALS), and for Purkinje neurons, the critical outflow cells of the cere-bellum. Moreover, targeted deletion of the GDNF gene results in renal dysgenesis and abnormal development of the enteric nervous system. GDNF mRNA is expressed in a complex temporospatial pattern in the central nervous system and the periphery, consistent with these observations. To begin elucidating mechanisms regulating the pattern of expression of GDNF, we have cloned the human gene, and characterized the promoter. The promoter is highly GC rich, and lacks canonical CCAT- box and TATA-box motifs. It contains more than 12 binding sites for known transcription factors. These cis-elements have the potential to interact with factors regulating constitutive expression (Sp1) and developmental expression (bHLH). Moreover, the promoter contains sites for binding transcription factors which respond to environmental signals, including CREB, AP2, Zif/268, NFkB, and MRE-BP. Combinatorial actions of these transcription factors may account for the extraordinarily complex expression patterns of the GDNF gene. Importantly, we demonstrate that the hGDNF gene utilizes a promoter distinct from that identified in the rodent GDNF gene, a finding with ramifications for Parkinson's disease and ALS research. Copyright 1998 Published by Elsevier Science B.V. |
